SCHEMBL6742541

SCHEMBL6742541

c1ccc(-c2ccc(-c3nc(-c4ccc(-c5ccccc5)cc4)nc(N4CCOCC4)n3)cc2)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTOR P42345 7/20 0.73
PIK3CA P42336 7/20 0.73
PIK3R1 P27986 3/20 0.73
HTT P42858 3/20 0.66
PIK3CG P48736 3/20 0.62
NPSR1 Q6W5P4 4/20 0.60
TSHR P16473 3/20 0.60
MAPT P10636 2/20 0.60
HSD17B10 Q99714 2/20 0.60
MAPK1 P28482 1/20 0.60
LMNA P02545 2/20 0.58
ATM Q13315 1/20 0.57
TDP1 Q9NUW8 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
CYP1A2 P05177 1/20 0.56
CYP2C9 P11712 1/20 0.56
CYP2C19 P33261 1/20 0.56
ALDH1A1 P00352 1/20 0.55
POLB P06746 1/20 0.54
GAA P10253 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12499681 0.85 PIK3CA (0.73) MTORPIK3CAPIK3R1HTTPIK3CG
SCHEMBL1309097 0.85 PIK3CA (1.00) MTORPIK3CAPIK3R1PIK3CG
SCHEMBL1309370 0.81 PIK3CA (0.71) MTORPIK3CAPIK3R1PIK3CG
SCHEMBL6736048 0.81 PIK3CA (0.66) MTORPIK3CAPIK3R1HTTPIK3CG
SCHEMBL4317272 0.80 HTT (0.58) MTORPIK3CAPIK3R1HTTPIK3CG
SCHEMBL13761287 0.79 HTT (0.61) MTORPIK3CAPIK3R1HTTPIK3CG
SCHEMBL1310041 0.79 MTOR (0.69) MTORPIK3CAPIK3R1HTTPIK3CG
SCHEMBL32704 0.79 MTOR (0.91) MTORPIK3CAPIK3CG
SCHEMBL6740369 0.79 LMNA (0.78) HTTTSHRMAPTLMNACYP1A2
SCHEMBL1309526 0.78 PIK3CA (0.66) MTORPIK3CAPIK3R1PIK3CGHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040082627-A1 Certain aromatic monocycles as kinase modulators CGI PHARMACEUTICALS, INC. 2004-04-29 US claimed
WO-2004000820-A2 CERTAIN AROMATIC MONOCYCLES AS KINASE MODULATORS CELLULAR GENOMICS, INC. (US) 2003-12-31 WO claimed
US-20040082627-A1 Certain aromatic monocycles as kinase modulators CGI PHARMACEUTICALS, INC. 2004-04-29 US disclosed
WO-2004000820-A2 CERTAIN AROMATIC MONOCYCLES AS KINASE MODULATORS CELLULAR GENOMICS, INC. (US) 2003-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040082627-A1 Certain aromatic monocycles as kinase modulators MAP3K20, MAP3K1, MAP3K19 MTOR 141/4885PIK3CA 249/4885PIK3R1 296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.